Immunofluorescence staining (Fig. 2D, E) and transcriptome data in The Cancer Genome Atlas (TCGA) database (Fig. 2F) also revealed no significant difference in P300 and HDAC1, 2, and 3 expressions between KRAS mutant and wild-type CRC tissues. This evidence concerns the gene KRAS and colorectal carcinoma.